dr peter attia semaglutide Peter Attia: Our conversation about his hit book OUTLIVE, Medicine 3.0, promoting healthspan, GLP-1 drugs and more The New Weight Loss Drugs

We are essential to helping individuals navigate the metabolic, emotional, and cultural shifts that accompany these therapies and to supporting safe and effective outcomes

A growing body of clinical evidence supporting tirzepatide is one reason insurers are evaluating coverage for Zepbound

Low blood sugar is more likely to happen if you also take a sulfonylurea or insulin

Note: MDPI stays neutral with regard to jurisdictional claims in published Chunarkar-Patil P et al (2024) Anticancer drug discovery based on natural products: from computational approaches to clinical studies

This blog is an extension of our poster presented at ISPOR 2024, titled Baseline A1C and BMI trends for people with type 2 diabetes receiving first-time GLP-1 RA prescriptions

My clients who had plateaued after 6 sessions started seeing results again immediately